1. Home
  2. GTBP vs FAMI Comparison

GTBP vs FAMI Comparison

Compare GTBP & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • FAMI
  • Stock Information
  • Founded
  • GTBP 1965
  • FAMI 2015
  • Country
  • GTBP United States
  • FAMI China
  • Employees
  • GTBP N/A
  • FAMI N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • FAMI Packaged Foods
  • Sector
  • GTBP Health Care
  • FAMI Consumer Staples
  • Exchange
  • GTBP Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • GTBP 2.6M
  • FAMI 2.1M
  • IPO Year
  • GTBP N/A
  • FAMI 2018
  • Fundamental
  • Price
  • GTBP $0.74
  • FAMI $1.31
  • Analyst Decision
  • GTBP Strong Buy
  • FAMI
  • Analyst Count
  • GTBP 1
  • FAMI 0
  • Target Price
  • GTBP $11.00
  • FAMI N/A
  • AVG Volume (30 Days)
  • GTBP 1.2M
  • FAMI 10.2K
  • Earning Date
  • GTBP 11-14-2025
  • FAMI 01-26-2026
  • Dividend Yield
  • GTBP N/A
  • FAMI N/A
  • EPS Growth
  • GTBP N/A
  • FAMI N/A
  • EPS
  • GTBP N/A
  • FAMI N/A
  • Revenue
  • GTBP N/A
  • FAMI $43,831,754.00
  • Revenue This Year
  • GTBP N/A
  • FAMI N/A
  • Revenue Next Year
  • GTBP N/A
  • FAMI N/A
  • P/E Ratio
  • GTBP N/A
  • FAMI N/A
  • Revenue Growth
  • GTBP N/A
  • FAMI N/A
  • 52 Week Low
  • GTBP $0.54
  • FAMI $1.28
  • 52 Week High
  • GTBP $4.10
  • FAMI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 53.14
  • FAMI 32.78
  • Support Level
  • GTBP $0.62
  • FAMI $1.40
  • Resistance Level
  • GTBP $1.15
  • FAMI $1.58
  • Average True Range (ATR)
  • GTBP 0.09
  • FAMI 0.07
  • MACD
  • GTBP 0.01
  • FAMI -0.01
  • Stochastic Oscillator
  • GTBP 34.74
  • FAMI 35.29

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: